FIGS, Inc. (FIGS) experienced a significant post-market surge, with its stock price soaring 6.66% during Thursday's extended trading session.

The sharp upward movement was driven by the company's release of its fourth quarter and full year 2025 financial results, which significantly exceeded analyst expectations. FIGS reported Q4 net revenues of $201.9 million, a 33% year-over-year increase that handily beat the consensus estimate of $165.3 million. The company's diluted earnings per share of $0.10 crushed the analyst estimate of $0.02, representing a 900% increase over the same period last year.

Furthermore, the healthcare apparel brand provided an optimistic outlook for fiscal year 2026, forecasting net revenue growth of 10% to 12% and an adjusted EBITDA margin between 12.7% and 12.9%. The strong performance was attributed to increased orders from new and existing customers, higher average order value, and robust international growth of 55.1% year-over-year.